vimarsana.com

Page 40 - ப்ரைம் அமைச்சர் திரு நரேந்திர மோடி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Indian and Mongolian Ministers discuss issues under Cultural Exchange Program

Indian and Mongolian Ministers discuss issues under Cultural Exchange Program Shri Patel explained the steps taken by the Govt of India to facilitate the visa and travel of Buddhist monks from Mongolia within India.Devdiscourse News Desk | New Delhi | Updated: 13-05-2021 18:30 IST | Created: 13-05-2021 18:30 IST Shri Patel thanked Ms Nomin for the special prayers conducted by some of the leading monasteries in Ulaanbaatar for India during the pandemic. Image Credit: Twitter(@prahladspatel) A meeting of the Minister of State for Culture & Tourism (Independent Charge) Shri Prahlad Singh Patel with the Mongolian Minister of Culture, Ms Chinbat Nomin was held today in virtual mode, to discuss various issues under the Cultural Exchange Program between the two countries, and other areas of common interest.

Govt ready to allow other companies to make Covaxin

Govt ready to allow other companies to make Covaxin Updated May 14, 2021, 12:00 am IST The government has now engaged five Public Sector Undertakings to help increase production of Covaxin  Covaxin. New Delhi: Under pressure from several states to increase the production of the two vaccines available in India, the Centre on Thursday said it is ready to allow private companies to manufacture the country s indigenous vaccine Covaxin. Covaxin is jointly developed by ICMR and Bharat Biotech and is currently being produced by Bharat Biotech. The government has now engaged five Public Sector Undertakings to help increase production of Covaxin. Since under this vaccine, live virus is inactivated, any company making this vaccine must have Bio-Safety Lab level 3 labs.

Cabinet approves Memorandum of Understanding between Institute of Chartered Accountants of India and Qatar Financial Centre Authority

New Delhi: The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi has approved signing of Memorandum of Understanding (MoU) between Institute of Chartered Accountants of India (ICAI) and Qatar Financial Centre Authority (QFCA).The MoU wo

Ministry of External Affairs of the Republic[ ] (via Public) / Telephone Conversation between Prime Minister Shri Narendra Modi and H E Dr Lotay Tshering, Prime Minister of Bhutan

05/11/2021 | Press release | Distributed by Public on 05/11/2021 02:52 Telephone Conversation between Prime Minister Shri Narendra Modi and H.E. Dr. Lotay Tshering, Prime Minister of Bhutan Prime Minister Shri Narendra Modi had a telephone conversation today with the Prime Minister of Bhutan, Lyonchhen Dr. Lotay Tshering. The Bhutan Prime Minister expressed solidarity with the Government and the people of India in their efforts against the recent wave of COVID-19 pandemic. Prime Minister conveyed his sincere thanks to the people and Government of Bhutan for their good wishes and support. He also appreciated the leadership of His Majesty the King in managing Bhutan s fight against the pandemic, and extended his best wishes to Lyonchhen for the continuing efforts.

DCGI Approves Anti-COVID Drug Developed by DRDO for Emergency Use, How Will it Work?

DCGI Approves Anti-COVID Drug Developed by DRDO for Emergency Use, How Will it Work? A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients and will be of immense benefit to the people suffering from COVID-19.   |  10 May 2021 7:14 AM GMT NEW DELHI: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy s Laboratories (DRL), Hyderabad. Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. The drug will be of immense benefit to the people suffering from COVID-19.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.